NCT06976892
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06976892
Title Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer (IDOL)
Acronym IDOL
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR


No variant requirements are available.